Aristo Bio-Tech & Lifescience Ltd
₹ 151
4.99%
21 Nov
- close price
About
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]
Key Points
- Market Cap ₹ 103 Cr.
- Current Price ₹ 151
- High / Low ₹ 164 / 53.1
- Stock P/E 17.6
- Book Value ₹ 56.0
- Dividend Yield 0.26 %
- ROCE 13.2 %
- ROE 12.2 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.70 times its book value
- The company has delivered a poor sales growth of 3.98% over past five years.
- Company has a low return on equity of 13.0% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 57 | 159 | 271 | 202 | 201 | 167 | 166 | 218 | 245 | 326 | |
| 56 | 157 | 263 | 195 | 197 | 163 | 161 | 209 | 236 | 315 | |
| Operating Profit | 1 | 3 | 7 | 7 | 5 | 4 | 5 | 9 | 8 | 11 |
| OPM % | 2% | 2% | 3% | 3% | 2% | 3% | 3% | 4% | 3% | 3% |
| 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 1 | 3 | 6 | 4 | 1 | 2 | 2 | 5 | 5 | 8 |
| Tax % | 33% | 31% | 34% | 31% | 28% | 29% | 27% | 25% | 28% | |
| 0 | 2 | 4 | 3 | 1 | 1 | 1 | 4 | 4 | 6 | |
| EPS in Rs | 4.00 | 18.52 | 37.44 | 5.67 | 2.02 | 2.16 | 2.10 | 5.23 | 5.73 | 8.62 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 5% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 14% |
| TTM: | 47% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 53% |
| TTM: | 64% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 99% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 13% |
| Last Year: | 12% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 5 | 5 | 5 | 5 | 7 | 7 | 7 |
| Reserves | 2 | 4 | 7 | 6 | 7 | 8 | 10 | 23 | 27 | 31 |
| 5 | 10 | 20 | 14 | 20 | 22 | 25 | 22 | 21 | 20 | |
| 20 | 72 | 60 | 65 | 56 | 46 | 37 | 47 | 73 | 165 | |
| Total Liabilities | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 223 |
| 2 | 2 | 8 | 8 | 8 | 12 | 14 | 16 | 22 | 23 | |
| CWIP | -0 | 0 | -0 | 1 | 3 | -0 | 0 | 1 | -0 | -0 |
| Investments | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| 25 | 85 | 81 | 81 | 77 | 69 | 63 | 83 | 106 | 200 | |
| Total Assets | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 223 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| -4 | 1 | 8 | 1 | 2 | 7 | -3 | 8 | ||
| 0 | -5 | -2 | -2 | -2 | -3 | -4 | -7 | ||
| 4 | 4 | -6 | 1 | -1 | -3 | 8 | -2 | ||
| Net Cash Flow | 0 | -0 | -0 | 0 | -0 | 0 | 1 | -1 |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 121 | 65 | 77 | 88 | 72 | 73 | 75 | 86 |
| Inventory Days | 66 | 67 | 42 | 65 | 47 | 78 | 60 | 57 | 65 |
| Days Payable | 142 | 177 | 85 | 124 | 74 | 93 | 87 | 85 | 112 |
| Cash Conversion Cycle | 16 | 11 | 23 | 18 | 61 | 56 | 46 | 48 | 38 |
| Working Capital Days | 30 | 26 | 27 | 28 | 37 | 51 | 56 | 56 | 47 |
| ROCE % | 31% | 34% | 24% | 14% | 11% | 11% | 16% | 13% |
Documents
Announcements
-
Outcome of Board Meeting
14 November 2024 - Aristo Bio-Tech And Lifescience Limited has informed regarding Board meeting held on November 14, 2024.
-
Financial Result Updates
14 November 2024 - Aristo Bio-Tech And Lifescience Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Board Meeting Intimation
13 November 2024 - ARISTO BIO-TECH AND LIFESCIENCE LIMITED has informed about Board Meeting to be held on 14-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results …
-
Board Meeting Intimation
8 November 2024 - ARISTO BIO-TECH AND LIFESCIENCE LIMITED has informed about Board Meeting to be held on 13-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results …
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
14 October 2024 - Aristo Bio-Tech And Lifescience Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
Business Overview:[1]
ABTL, an ISO 9001:2008 certified company, manufactures, formulates, supplies, and packages various pesticides, including insecticides, herbicides, fungicides, plant growth regulators, and other agrochemicals. It currently has 257 products registered with CIB&RC for manufacturing and sales, serving both domestic and international customers.